CD33 and Alzheimer disease: In addition to CD33 and CD74 [40, 47], other AD genes (ABCA7 and TREM2) are also expressed in microglia [48, 49], suggesting that the modulation of microglial function may be a promising mechanism-based strategy for AD intervention.